Alentis Therapeutics
Leadership & Board
Key Executives
CEOAndrea Pellacani
CEORoberto Iacone
Chief Executive OfficerMark Pruzanski
Chief Business OfficerRizwan Velji
Current Number of Employees69
Current LinkedIn Followers14,071
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$181M
Total Amount Raised$181M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$181M
Latest Funding Amount$181M
Latest Funding RoundSeries D
Latest Funding RoundSeries D
Post-Money Valuation―
Post-Money Valuation―
Company Momentum Positive
Articles Published on TipRanks3
Articles Published on TipRanks
3
LinkedIn Trend+0.25% followers
LinkedIn Trend
+0.25% followers
Workforce Trend1.4% employees
Workforce Trend
1.4% employees
Alentis Therapeutics LinkedIn following is increasing, signaling rising market interest, while its workforce size remains relatively unchanged.
Company Momentum indicates whether the company is gaining or losing traction over time. This proprietary TipRanks metric analyzes changes in a company’s workforce and LinkedIn follower trends, balancing these signals together to generate an overall momentum sentiment.
Employee Trend
Alentis Therapeutics had 69 employees as of May 18, 2026. The number of employees decreased by 1 (1.43%) week-over-week.
69Latest Employee Count
1(-1.43%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Alentis Therapeutics had 14,071 followers as of May 18, 2026. The number of followers increased by 35 (0.25%) week-over-week.
14,071Latest Followers Count
35(0.25%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.
Funding Round
Aug 14, 2025
Series D
$181.40M
―
Investors
Series D
